MarketsandMarkets Orphan Drugs and Rare Diseases Conference – US Edition

MarketsandMarkets Orphan Drugs and Rare Diseases Conference – US Edition is organized by MarketsandMarkets Conferences and will be held from Oct 17 - 18, 2024 at Boston, Massachusetts, United States of America.

Description:
The conference will focus on the wide scope of orphan drug developments, critical issues of elevated pricing, reimbursement & access to patients, and strategies to enhance access to novel diagnostics and effective therapies for rare to ultra–rare diseases.

Key Highlights:
Overview and Regulatory Updates: Current Landscape and Regulatory Developments in US Market.
Emerging Therapies for RDs: Recent breakthroughs in CRISPR-Cas9 technology, Cell & Gene Therapies, mRNA therapies & Precision Treatments.
Rare Disease and Genetics: Rare Genetic Disease Mechanisms and Therapeutic Targets.
Patient Advocacy, Engagement & Collaboration: Critical Role of Patient Advocacy and Global Collaboration in Research and Development.
Global Perspectives and Market Access: Global market dynamics and market access strategies, sustainable models & roadblocks for orphan drugs.
Drug Discovery & Clinical Trial design: Novel drug discoveries and clinical trial implementation & management for rare diseases.
Diagnostics & Care: Biomarker Discovery, Digital health/AI applications, Genetic Testing, NGS Technologies for Early Detection and Monitoring.
Pricing, Reimbursement & HTA: Health Technology Assessment on decision-making, challenges on high pricing, reimbursement & Commercialization.
OD Manufacturing and Supply Chain: Specialized manufacturing and supply chain solutions for orphan drugs.
Rare to Ultra Rare Diseases: Emerging Therapies and Distinctive Obstacles in the Identification, Therapy, and Sustained Care of different rare/Ultra Rare diseases in children and adults.
Ethical and Legal Considerations: Ethical dilemmas, patient privacy concerns, and legal issues surrounding rare disease research, and data sharing.

Why Attend? Discover Compelling Reasons to Join Us
• Hear from influential keynote speakers who share their experiences, insights, and visions for the future.
• Get access to the latest research findings, innovative therapies, and breakthroughs in the field.
• Platform to exchange insights, discoveries, and best practices in the realm of orphan drugs and rare diseases.
• Participate in discussions with experts on how to tackle the critical issues shaping the future of orphan drugs.
• Discover and brainstorm ways to advance orphan drug development and improve access to life-saving therapies.
• Gain awareness about rare diseases and the challenges associated with developing treatments for these conditions.
• Collaboration & Networking Opportunities between academia, industry, and advocacy groups, fostering partnerships aimed at accelerating research, drug development, and access to therapies for rare diseases.